Justin L. Grobe

Justin L. Grobe

Auto-generated profile, based on publicly available information

Justin L. Grobe

Medical College of Wisconsin

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
JGJustin L. Grobe
Justin L. Grobe
AMAdam P. Mecca
Adam P. Mecca
MLMelissa Lingis
Melissa Lingis
VSVinayak Shenoy
Vinayak Shenoy
TBTonya A. Bolton
Tonya A. Bolton
MKMichael J. Katovich
Michael J. Katovich
Cardiac remodeling, which typically results from chronic hypertension or following an acute myocardial infarction, is a major risk factor for the development of heart failure and, ultimately, death. The renin-angiotensin system (RAS) has previously been established to play an important role in the progression of cardiac remodeling, and inhibition of a hyperactive RAS provides protection from cardiac remodeling and subsequent heart failure. Our previous studies have demonstrated that overexpression of angiotensin-converting enzyme 2 (ACE2) prevents cardiac remodeling and hypertrophy during chronic infusion of angiotensin II (ANG II). This, coupled with the knowledge that ACE2 is a key enzyme in the formation of ANG-(1–7), led us to hypothesize that chronic infusion of ANG-(1–7) would prevent cardiac remodeling induced by chronic infusion of ANG II. Infusion of ANG II into adult Sprague-Dawley rats resulted in significantly increased blood pressure, myocyte hypertrophy, and midmyocardial interstitial fibrosis. Coinfusion of ANG-(1–7) resulted in significant attenuations of myocyte hypertrophy and interstitial fibrosis, without significant effects on blood pressure. In a subgroup of animals also administered [d-Ala7]-ANG-(1–7) (A779), an antagonist to the reported receptor for ANG-(1–7), there was a tendency to attenuate the antiremodeling effects of ANG-(1–7). Chronic infusion of ANG II, with or without coinfusion of ANG-(1–7), had no effect on ANG II type 1 or type 2 receptor binding in cardiac tissue. Together, these findings indicate an antiremodeling role for ANG-(1–7) in cardiac tissue, which is not mediated through modulation of blood pressure or altered cardiac angiotensin receptor populations and may be at least partially mediated through an ANG-(1–7) receptor.

6 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
MOMegan Ann Opichka
Megan Ann Opichka
MRMatthew W. Rappelt
Matthew W. Rappelt
DGDavid Gutterman
David Gutterman
JGJustin L. Grobe
Justin L. Grobe
JMJennifer Jury McIntosh
Jennifer Jury McIntosh
Preeclampsia is a life-threatening pregnancy-associated cardiovascular disorder characterized by hypertension and proteinuria at 20 weeks of gestation. Though its exact underlying cause is not precisely defined and likely heterogenous, a plethora of research indicates that in some women with preeclampsia, both maternal and placental vascular dysfunction plays a role in the pathogenesis and can persist into the postpartum period. Potential abnormalities include impaired placentation, incomplete spiral artery remodeling, and endothelial damage, which are further propagated by immune factors, mitochondrial stress, and an imbalance of pro- and antiangiogenic substances. While the field has progressed, current gaps in knowledge include detailed initial molecular mechanisms and effective treatment options. Newfound evidence indicates that vasopressin is an early mediator and biomarker of the disorder, and promising future therapeutic avenues include mitigating mitochondrial dysfunction, excess oxidative stress, and the resulting inflammatory state. In this review, we provide a detailed overview of vascular defects present during preeclampsia and connect well-established notions to newer discoveries at the molecular, cellular, and whole-organism levels.

14 September 2005 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
MHMatthew J. Huentelman
Matthew J. Huentelman
JGJustin L. Grobe
Justin L. Grobe
JVJorge Vazquez
Jorge Vazquez
JSJillian M. Stewart
Jillian M. Stewart
AMAdam P. Mecca
Adam P. Mecca
MRMohan K. Raizada
Mohan K. Raizada

1 June 2006 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
JGJustin L. Grobe
Justin L. Grobe
AMAdam P. Mecca
Adam P. Mecca
HMHaoyu Mao
Haoyu Mao
MKMichael J. Katovich
Michael J. Katovich
Cardiac remodeling is a hallmark hypertension-induced pathophysiology. In the current study, the role of the angiotensin-(1–7) fragment in modulating cardiac remodeling was examined. Sprague-Dawley rats underwent uninephrectomy surgery and were implanted with a deoxycorticosterone acetate (DOCA) pellet. DOCA animals had their drinking water replaced with 0.9% saline solution. A subgroup of DOCA-salt animals was implanted with osmotic minipumps, which delivered angiotensin-(1–7) chronically (100 ng·kg−1·min−1). Control animals underwent sham surgery and were maintained on normal drinking water. Blood pressure was measured weekly with the use of the tail-cuff method, and after 4 wk of treatment, blood pressure responses to graded doses of angiotensin II were determined by direct carotid artery cannulation. Ventricle size was measured, and cross sections of the heart ventricles were paraffin embedded and stained using Masson's Trichrome to measure interstitial and perivascular collagen deposition and myocyte diameter. DOCA-salt treatment caused significant increases in blood pressure, cardiac hypertrophy, and myocardial and perivascular fibrosis. Angiotensin-(1–7) infusion prevented the collagen deposition effects without any effect on blood pressure or cardiac hypertrophy. These results indicate that angiotensin-(1–7) selectively prevents cardiac fibrosis independent of blood pressure or cardiac hypertrophy in the DOCA-salt model of hypertension.

1 November 2010 in Cell Metabolism
Verified
Journal Article
Closed access
JGJustin L. Grobe
Justin L. Grobe
CGConnie L. Grobe
Connie L. Grobe
TBTerry G. Beltz
Terry G. Beltz
SWScott G. Westphal
Scott G. Westphal
DMDonald A. Morgan
Donald A. Morgan
CSCurt D. Sigmund
Curt D. Sigmund

1 August 2008 in Physiology
Verified
Journal Article
Open access
PDF file
JGJustin L. Grobe
Justin L. Grobe
DXDi Xu
Di Xu
CSCurt D. Sigmund
Curt D. Sigmund
The renin-angiotensin system in the brain acts to regulate a number of physiological processes. Evidence suggests that angiotensin peptides may act as neurotransmitters, although their biosynthetic pathways are poorly understood. We review evidence for neuronal production of angiotensin peptides and hypothesize that angiotensin may be synthesized intracellularly in neurons.